Neuroscience Antibodies & Assays Global Market Report 2024 by The Business Research Company | Abcam plc, BioLegend Inc., Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Merck KGaA, Rockland Imm

The neuroscience antibodies & assays market size has grown rapidly in recent years. It will grow from $4.1 billion in 2023 to $4.63 billion in 2024 at a compound annual growth rate (CAGR) of 13.0%. The growth in the historic period can be attributed to research funding, drug discovery and development, neurodegenerative diseases, government initiatives, personalized medicine.

The neuroscience antibodies & assays market size is expected to see rapid growth in the next few years. It will grow to $7.68 billion in 2028 at a compound annual growth rate (CAGR) of 13.5%. The growth in the forecast period can be attributed to collaborations, telemedicine in neurology, education and training, biomarker-driven therapies, neuroimmunology focus . Major trends in the forecast period include microrna and non-coding rna assays, digital pathology, advanced imaging-compatible assays, single-cell analysis, 3d organoid models.

Request A Sample Of This Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=7548&type=smp

Neuroscience Antibodies & Assays Market Major Segments
The neuroscience antibodies & assays market covered in this report is segmented -

1) By Product: Consumables, Instruments
2) By Technology: Molecular Diagnostics, Clinical Chemistry, Immunoassays Or Immunochemistry, Others Technologies
3) By Application: In Vitro Diagnostics, Research, Drug Discovery
4) By End User: Hospitals And Diagnostics Centers, Academic And Research Institutes, Pharmaceutical And Biotechnology Companies

Key Driver - Surge In Neurological Illnesses Spurs Remarkable Growth In The Neuroscience Antibodies & Assays Market

The increase in incidents of neurological illnesses across the globe are expected to propel the growth of the neuroscience antibodies & assays market going forward. Neurological illnesses are disorders and affecting the nervous system, and examples of neurological disorders include epilepsy, Alzheimer's disease, dementia, and so on. The rise in the number of neurological illnesses requires more research and development activities for the treatment of these diseases. Antibodies and assays are used in research and development activities to study development, systems, structure and function, and disorders and degeneration of the nervous system. Thus, the neuroscience antibodies & assays market grows with the increase in incidents of neurological illnesses. For instance, According to the World Health Organization, a Switzerland-based health promotion agency 55 million people live with dementia globally, and there are nearly 10 million new cases every year as per 2021 data. According to Alzheimer's Association a US based Non-profit association, 6.5 million people in the US have Alzheimer's disease as per 2022 data. As a result, the increased incidence of neurological illnesses across the world is driving the neuroscience antibodies and assays market forward.

Customise This Report As Per Your Requirements - https://www.thebusinessresearchcompany.com/Customise?id=7548&type=smp

Prominent Trend - Neuronexus Summa Framework Sets New Technological Standard In Antibodies And Assays Market

Technological advancements are a key trend gaining popularity in the neuroscience antibodies and assays market. Major companies operating in the market are introducing new technologies such as NeuroNexus Summa Framework technology to sustain their position in the market. For instance, in February 2022 NeuroNexus Technologies, a US-based innovative neural interface products and technologies provider announced the launch of NeuroNexus Summa Framework. The solution was designed for both experienced electrophysiologists and life science researchers who are looking to easily incorporate electrical signal read-outs from biological cells and tissues into their research workflow.

Neuroscience Antibodies & Assays Market Players
Major companies operating in the neuroscience antibodies & assays market include Abcam plc, BioLegend Inc., Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Merck KGaA, Rockland Immunochemicals Inc., GenScript Biotech Corporation, Santa Cruz Biotechnology Inc., Wak-Chemie Medical GmbH, Epitope Diagnostics Inc., Agilent Technologies, Bio-Techne Corporation, Creative Diagnostics, Enzo Life Sciences Inc., Jackson ImmunoResearch Laboratories Inc., Novus Biologicals LLC, OriGene Technologies Inc., Proteintech Group Inc., R&D Systems Inc., RayBiotech Inc., StressMarq Biosciences Inc., Synaptic Systems GmbH, Tocris Bioscience, Alomone Labs Ltd., AnaSpec Inc., Antibodies.com, Antibody Solutions, Arbor Assays, Uscn Life Science Inc., Zymo Research Corp., AAT Bioquest Inc., Abbexa Ltd., ACROBiosystems Inc., Active Motif Inc., AdipoGen Life Sciences, Advanced Targeting Systems Inc., AgriSera AB

View The Full Report Here - https://www.thebusinessresearchcompany.com/report/neuroscience-antibodies-and-assays-global-market-report

Largest And Fastest Growing Region In The Market
North America was the largest region in the neuroscience antibodies & assays market in 2023. The regions covered in the neuroscience antibodies & assays market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Neuroscience Antibodies & Assays Market Report Structure
3. Neuroscience Antibodies & Assays Market Trends And Strategies
4. Neuroscience Antibodies & Assays Market - Macro Economic Scenario
5. Neuroscience Antibodies & Assays Market Size And Growth
…..
27. Neuroscience Antibodies & Assays Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.